• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国分级医疗体系下慢性阻塞性肺疾病急性加重的管理。

Management of acute exacerbation of chronic obstructive pulmonary disease under a tiered medical system in China.

机构信息

Department of Respiratory and Critical Care Medicine, Shanghai Institute of Respiratory Disease, Zhongshan Hospital, Fudan University, Shanghai, China Department of Respiratory and Critical Care Medicine, the Affiliated Hospital of Qingdao University, Qingdao, China

Pulmonary and Critical Care Medicine, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221075499. doi: 10.1177/17534666221075499.

DOI:10.1177/17534666221075499
PMID:35156477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8848085/
Abstract

BACKGROUND

The Chinese government has promoted the 'tiered medical services' policy in which diseases are classified by severity, mode of onset and difficulty of treatment since 2015 to optimize medical resources. We evaluated the diagnosis and treatment of acute exacerbation (AE) of chronic obstructive pulmonary disease (AECOPD) under the tiered system.

METHODS

We conducted a cross-sectional study. COPD characteristics and treatments were compared among hospitals in different tiers. Associations were examined by univariate and multivariable logistic regression analysis. In addition, multivariate logistic regression was performed to identify the possible influencing factors of antibiotics, glucocorticoids and anticoagulant usages.

RESULTS

Eligible COPD patients ( = 432) were consecutively recruited from eight hospitals in different tiers in China. Patients in the countryside preferred the community hospitals, whereas patients in cities preferred second-tier and teaching hospitals when they suffer from AECOPD. It indicates most COPD patients are likely to treat their disease locally. The severity of COPD AE increased with tiers of hospitals ( < 0.001). However, our results clearly show that most community hospitals can only deal with mild exacerbation of COPD. Approximately 90% of AE patients received antibiotics. We speculated that antibiotics abuse might exist in the three tiers of hospitals. Multivariate analysis demonstrated that long-term antibiotics usage (⩾14 days) was associated with moderate exacerbation [odds ratio (OR): 5.295, 95% confidence intervals (CI) 2.248-12.473,  < 0.001], radiographic progression (OR: 2.176, 95% CI: 1.047-4.522,  = 0.037), positive sputum etiology (OR: 3.073, 95% CI: 1.477-6.394,  = 0.003) and increased white blood cells (OR: 2.470, 95% CI: 1.190-5.126,  = 0.015). The proportion of glucocorticoids increased with the hospital hierarchy (18.6% 45.6% 69.2%,  < 0.001). The proportions of severe cases in the second-tier hospitals were 26.9%; however, non-invasive positive pressure ventilation (NPPV) rate was only 14.7%. Anticoagulant is not commonly used in AECOPD, and the community hospitals had the lowest proportion of anticoagulation regimen (1.7% 14.3% 20.5%,  = 0.002).

CONCLUSIONS

The 'tiered medical services' policy in AECOPD management has been unsatisfactory in the past years. Irrational treatment strategies in different hospitals were still found when comparing with international guideline. Further reform of the policy is still needed to optimize the management of AECOPD in China.

摘要

背景

自 2015 年以来,中国政府推行了“分级医疗服务”政策,根据疾病的严重程度、发病方式和治疗难度对疾病进行分类,以优化医疗资源。我们评估了分级系统下慢性阻塞性肺疾病急性加重(AECOPD)的诊断和治疗。

方法

我们进行了一项横断面研究。比较了不同层级医院的 COPD 特征和治疗方法。采用单因素和多因素逻辑回归分析来检验关联。此外,还进行了多变量逻辑回归分析,以确定抗生素、糖皮质激素和抗凝剂使用的可能影响因素。

结果

从中国 8 家不同层级的医院连续招募了 432 名符合条件的 COPD 患者。农村患者更喜欢社区医院,而城市患者在患 AECOPD 时更喜欢二级和教学医院。这表明大多数 COPD 患者可能会在当地治疗他们的疾病。AECOPD 的严重程度随着医院的层级而增加( < 0.001)。然而,我们的结果清楚地表明,大多数社区医院只能处理 COPD 的轻度加重。大约 90%的 AE 患者接受了抗生素治疗。我们推测,抗生素滥用可能存在于三个层级的医院中。多因素分析表明,长期使用抗生素(≥14 天)与中度加重有关[比值比(OR):5.295,95%置信区间(CI):2.248-12.473,  < 0.001]、影像学进展(OR:2.176,95%CI:1.047-4.522,  = 0.037)、痰病原阳性(OR:3.073,95%CI:1.477-6.394,  = 0.003)和白细胞增多(OR:2.470,95%CI:1.190-5.126,  = 0.015)。糖皮质激素的比例随着医院等级的增加而增加(18.6% 45.6% 69.2%,  < 0.001)。二级医院的重症比例为 26.9%;然而,无创正压通气(NPPV)的使用率仅为 14.7%。AECOPD 中抗凝剂不常用,社区医院抗凝方案的比例最低(1.7% 14.3% 20.5%,  = 0.002)。

结论

在过去几年中,AECOPD 管理中的“分级医疗服务”政策并不令人满意。与国际指南相比,我们仍然发现不同医院的治疗策略不合理。仍需要对该政策进行进一步改革,以优化中国 AECOPD 的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/34ede162113f/10.1177_17534666221075499-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/9ebb32bd2f65/10.1177_17534666221075499-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/f29257098d93/10.1177_17534666221075499-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/a84ff3682631/10.1177_17534666221075499-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/406196181e05/10.1177_17534666221075499-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/23cdec2e98eb/10.1177_17534666221075499-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/34ede162113f/10.1177_17534666221075499-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/9ebb32bd2f65/10.1177_17534666221075499-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/f29257098d93/10.1177_17534666221075499-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/a84ff3682631/10.1177_17534666221075499-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/406196181e05/10.1177_17534666221075499-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/23cdec2e98eb/10.1177_17534666221075499-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f33a/8848085/34ede162113f/10.1177_17534666221075499-fig6.jpg

相似文献

1
Management of acute exacerbation of chronic obstructive pulmonary disease under a tiered medical system in China.中国分级医疗体系下慢性阻塞性肺疾病急性加重的管理。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221075499. doi: 10.1177/17534666221075499.
2
Stable Chronic Obstructive Pulmonary Disease (COPD) Management Under a Tiered Medical System in China.中国分级医疗体系下稳定期慢性阻塞性肺疾病(COPD)的管理。
Int J Chron Obstruct Pulmon Dis. 2022 Jan 14;17:181-194. doi: 10.2147/COPD.S333274. eCollection 2022.
3
Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的恶化:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167353. doi: 10.1177/17534666231167353.
4
Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study.中国 COPD 加重期患者糖皮质激素的使用:一项回顾性观察研究。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618769514. doi: 10.1177/1753466618769514.
5
[Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].[慢性阻塞性肺疾病急性加重伴二氧化碳潴留患者全身应用糖皮质激素相关因素的临床研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1061-1066. doi: 10.3760/cma.j.cn121430-20200302-00203.
6
Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study.开发和验证一种多变量预测模型,以识别中国 COPD 急性加重及其严重程度,用于 COPD 管理(DETECT 研究):一项多中心、观察性、横断面研究。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 5;17:2093-2106. doi: 10.2147/COPD.S363935. eCollection 2022.
7
Complexity in clinical diagnoses of acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重症的临床诊断复杂性。
BMC Pulm Med. 2023 Aug 14;23(1):298. doi: 10.1186/s12890-023-02587-1.
8
[Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].[慢性阻塞性肺疾病患者急性加重的理解与识别]
Zhonghua Liu Xing Bing Xue Za Zhi. 2013 Oct;34(10):1030-4.
9
Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study.中国工业地区慢性阻塞性肺疾病急性加重的危险因素:一项多中心横断面研究
Int J Chron Obstruct Pulmon Dis. 2020 Sep 24;15:2249-2256. doi: 10.2147/COPD.S270729. eCollection 2020.
10
Multiple Factor Analysis of Depression and/or Anxiety in Patients with Acute Exacerbation Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病急性加重期患者抑郁和/或焦虑的多因素分析。
Int J Chron Obstruct Pulmon Dis. 2020 Jun 19;15:1449-1464. doi: 10.2147/COPD.S245842. eCollection 2020.

引用本文的文献

1
Treatment patterns for chronic obstructive pulmonary disease under the tiered medical system.分级医疗体系下慢性阻塞性肺疾病的治疗模式
Sci Rep. 2025 Jan 4;15(1):844. doi: 10.1038/s41598-024-85010-x.
2
Knowledge, attitudes and practices among patients with periodontal disease toward disease management.牙周病患者对疾病管理的认知、态度和行为
Front Public Health. 2024 Dec 6;12:1500586. doi: 10.3389/fpubh.2024.1500586. eCollection 2024.
3
Clinical evaluation of ventilation mode on acute exacerbation of chronic obstructive pulmonary disease with respiratory failure.

本文引用的文献

1
Occupational chronic obstructive pulmonary disorder: prevalence and prevention.职业性慢性阻塞性肺疾病:患病率与预防
Expert Rev Respir Med. 2022 Apr;16(4):429-436. doi: 10.1080/17476348.2021.2011722. Epub 2021 Dec 6.
2
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.
3
通气模式对慢性阻塞性肺疾病急性加重伴呼吸衰竭的临床评估
World J Clin Cases. 2023 Sep 16;11(26):6040-6050. doi: 10.12998/wjcc.v11.i26.6040.
4
The "Trinity" smart hospital construction policy promotes the development of hospitals and health management in China.“三位一体”智慧医院建设政策推动中国医院和卫生管理发展。
Front Public Health. 2023 Jul 21;11:1219407. doi: 10.3389/fpubh.2023.1219407. eCollection 2023.
5
CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity.CC16 作为诱导痰中的炎症生物标志物反映慢性阻塞性肺疾病(COPD)的严重程度。
Int J Chron Obstruct Pulmon Dis. 2023 Apr 27;18:705-717. doi: 10.2147/COPD.S400999. eCollection 2023.
6
Treatment patterns in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的治疗模式:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231158283. doi: 10.1177/17534666231158283.
7
Nebulized corticosteroids systemic corticosteroids for patients with acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis comparing the benefits and harms reported by observational studies and randomized controlled trials.雾化吸入糖皮质激素与全身使用糖皮质激素治疗慢性阻塞性肺疾病急性加重期患者:一项系统评价和荟萃分析,比较观察性研究和随机对照试验报告的益处和危害
Front Pharmacol. 2022 Oct 5;13:966637. doi: 10.3389/fphar.2022.966637. eCollection 2022.
The availability, price and affordability of essential antibacterials in Hubei province, China.
中国湖北省基本抗菌药物的可及性、价格及可负担性
BMC Health Serv Res. 2018 Dec 29;18(1):1013. doi: 10.1186/s12913-018-3835-x.
4
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.中国慢性阻塞性肺疾病患病率及危险因素研究(CPH 研究):一项全国性横断面研究。
Lancet. 2018 Apr 28;391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. Epub 2018 Apr 9.
5
Exacerbations of COPD.COPD 恶化。
Eur Respir Rev. 2018 Mar 14;27(147). doi: 10.1183/16000617.0103-2017. Print 2018 Mar 31.
6
Chronic obstructive pulmonary disease.慢性阻塞性肺疾病。
Lancet. 2017 May 13;389(10082):1931-1940. doi: 10.1016/S0140-6736(17)31222-9. Epub 2017 May 11.
7
Deadly Sins of Antibiotic Abuse in China.中国抗生素滥用的七大罪
Infect Control Hosp Epidemiol. 2017 Jun;38(6):758-759. doi: 10.1017/ice.2017.60. Epub 2017 Apr 11.
8
Acute exacerbation of COPD.慢性阻塞性肺疾病急性加重
Respirology. 2016 Oct;21(7):1152-65. doi: 10.1111/resp.12780. Epub 2016 Mar 30.
9
Global burden of COPD.慢性阻塞性肺疾病的全球负担。
Respirology. 2016 Jan;21(1):14-23. doi: 10.1111/resp.12660. Epub 2015 Oct 23.
10
Withdrawal of inhaled glucocorticoids and exacerbations of COPD.吸入性糖皮质激素的撤药与 COPD 恶化。
N Engl J Med. 2014 Oct 2;371(14):1285-94. doi: 10.1056/NEJMoa1407154. Epub 2014 Sep 8.